Do you want to read an article? Please log in or register.
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials
Heart, Artery and Coronary Diseases
RECOMMENDED
Related content
Atrial FibrillationThrombosis and Stroke
The Effect of Implantable Loop Recorder based Continuous Rhythm Monitoring on Incident Atrial Fibrillation and Stroke: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Heart Rhythm
Asad ZUA, Krishan S, Agarwal S, Khan MS, Piccini JP, Reynolds DW
doi: 10.1016/j.hrthm.2024.05.059
Cardiovascular Risk and Diseases
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial
Lancet Diabetes Endocrinol
Hauge JW, Borgeraas H, Birkeland KI, Johnson LK, Hertel JK, Hagen M, Gulseth HL, Lindberg M, Lorentzen J, Seip B, Kolotkin RL, Svanevik M, Valderhaug TG, Sandbu R, Hjelmesæth J, Hofsø D
doi: 10.1016/S2213-8587(24)00396-6
RECOMMENDED
Hypertension
Efficacy and Safety of Aldosterone Synthase Inhibitors for Hypertension: A Meta-Analysis of Randomized Controlled Trials and Systematic Review
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Marzano L, Merlo M, Martinelli N, Pizzolo F, Friso S
doi: 10.1161/HYPERTENSIONAHA.124.23962
Heart, Artery and Coronary DiseasesTherapy and Intervention
Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials
J Am Heart Assoc
Kazemian S, Fallahtafti P, Sharifi M, Mohammadi NSH, Soleimani H, Moghadam AS, Karimi E, Sattar Y, Jenab Y, Mehrani M, Hajizeinali A, Iskander M, Sabet MF, Salehi N, Al-Azizi K, Hakim D, Alam M, Hosseini K
doi: 10.1161/JAHA.124.036179
Heart, Artery and Coronary DiseasesTherapy and Intervention
Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention: Meta-Analysis of Randomized Controlled Trials
JACC Cardiovasc Interv
Sedhom R, Hamed M, Elbadawi A, Mohsen A, Swamy P, Athar A, Bharadwaj AS, Prasad V, Elgendy IY, Alfonso F
doi: 10.1016/j.jcin.2024.04.042
Cardiovascular Risk and DiseasesFurther Publications
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical Trial
JAMA Cardiol
Peikert A, Claggett BL, Udell JA, Joseph J, Hegde SM, Kim K, Mao L, Wang T, Havighurst TC, Farkouh ME, Bhatt DL, Tattersall MC, Cooper LS, Solomon SD, Vardeny O
doi: 10.1001/jamacardio.2024.0468
Heart, Artery and Coronary Diseases
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial
Am Heart J
Haff N, Horn DM, Bhatkhande G, Sung M, Colling C, Wood W, Robertson T, Gaposchkin D, Simmons L, Yang J, Yeh J, Crum KL, Hanken KE, Lauffenburger JC, Choudhry NK
doi: 10.1016/j.ahj.2025.02.007
RECOMMENDED
Cardiovascular Risk and DiseasesFurther Publications
Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease: A Randomized Clinical Trial
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Klug EQ, Llerena S, Burgess LJ, Fourie N, Scott R, Vest J, Caldwell K, Kallend D, Stein EA, LIBERATE-HR Investigators
doi: 10.1001/jamacardio.2024.1659
Cardiovascular Risk and Diseases
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial
JAMA Cardiol
Kandula NR, Shah NS, Kumar S, Charley M, Clauson M, Lancki N, Finch EA, Ehrlich-Jones L, Rao G, Spring B, Shah NS, Siddique J
doi: 10.1001/jamacardio.2024.2526